Tadalafil gehört zur Gruppe der PDE5-Hemmer und wirkt über eine hochselektive Blockade des Enzyms Phosphodiesterase Typ 5. Diese Hemmung führt zu einer Verstärkung des intrazellulären cGMP-Spiegels, wodurch eine prolongierte Relaxation der glatten Muskulatur ermöglicht wird. Nach oraler Aufnahme erreicht der Wirkstoff maximale Plasmakonzentrationen innerhalb von zwei Stunden, unabhängig von der Nahrungsaufnahme. Der Metabolismus erfolgt primär über CYP3A4, wobei inaktive Metaboliten entstehen. Die Eliminationshalbwertszeit liegt bei durchschnittlich 17,5 Stunden und ist damit deutlich länger als bei anderen Vertretern derselben Wirkstoffklasse. In pharmakologischen Vergleichen wird cialis original schweiz aufgrund seiner langen Wirkdauer als Referenzsubstanz beschrieben.

Microsoft word - type_drug_chart[1]

EMT-I Drugs
Type of Drug
Route + Dosage
Epinephrine 1:10,000
IV -1:10,000
Cardiac Arrest: 1mg q 3-5 min
Bradycardia:
Stimulator/Vasoconstrictor Vasopressin
40 units one time only, after 10 min if no Atropine
Asystole/PEA: 1mg
Bradycardia:
mg
Poisoning:
Amiodarone
Cardiac Arrest: 300 mg IV bolus, repeat
If converted:
Antiarrhythmic
Tachycardia:
Lidocaine 2% / 20%
Pulseless V-tack/V-fib: 1-1.5 mg/kg q
5-8 min, max 3 mg/kg
V-tach w/pulse/PVC’s: : 1-1.5 mg/kg q
5-8 min, max 3 mg/kg
[If pt. > 70 w/CHF or hepatic failure, 
2nd dose to ¼ of 1st dose]
Post conversion:
Nitroglycerine
Ointment: ½ - 1 ½ inches on skin
Vasodilator
completion of the action
potential
Benadryl
Antihistamine
Antihistamine, H1 and H2
blocker
Lasix
Diuretic
Activated Charcoal
- Adsorbant
Antidote
IV / IO / SQ / IM / IN
- Non-opioid analgesic
MI / Angina: 81-625 mg/day
inflammatory (NSAID)- Antipyretic (to reduce fever)- Antiplatelet - Non-opioid analgesic
IM (single dose):
IV / IO (single dose): 15-30 mg
Analgesic
IV / IO / SQ / IM
Morphine
IV / IO / SQ / IM
Controlled substance,
schedule II
Epinephrine 1:1,000
Atrovent
NEBULAZED
Albuterol
- Adrenergic  agonist (it NEBULAZED Inhaler
Bronchodilator
Combi-vent
NEBULAZED
Ipratropium (Atrovent) 18 mcg
Albuterol 103 mcg in 3 mL saline
Albuterol 103
mcg/actuation
Glucagon
IM / SQ / Slow IV
Antihypoglycemic
Antihypoglycemic
Oral Glucose
Agonist: drug that interact w/receptor to stimulate a response.
Epinephrine: non-specific adrenergic agonist, interact w/Alpha 1 & Beta 1 & 2 receptors
Albuterol: adrenergic Beta 2 agonist
Morphine: depresses pain impulses transmission by interacting w/opioids receptors
Fentanyl: depresses pain impulses transmission by interacting w/opioids receptors
ANTAgonist: drug that interact w/receptor to prevent a response
Narcan: opioid antagonist that competes w/opioids at opioids receptor sites
Benadryl: competes w/histamine for H1 and H2 receptor sites
Atropine: blocks acetylcholine at postganglionic receptor sites
Atrovent: inhibits interaction of acetylcholine at receptor sites
Amiodarone: non competitive Alpha and Beta adrenergic blocker
Partial agonist: drugs that interact w/receptor to stimulate a response but inhibit other responses.
Nubain: synthetic opioid agonist + antagonist. Depresses pain impulse transmission by interacting w/opioid
receptors. It has antagonist effects similar to those of Narcan.
Anticholinergic = Parasympatholytics
Atropine
Atrovent
Sympathetic
Sympathomimetic
Sympatholytic
BRONCHODILATORS
 Epinephrine 1:1,000 Atrovent Albuterol Combi-vent ANALGESICS
Opioids: (for respiratory depression induced by opioids use Narcan)
 Nubain (synthetic opioid) Morphine (opioid analgesic) Fentanyl (very potent opioid analgesic) CARDIAC
Cardiac stimulator / Vasoconstrictor
:
Antiarrhythmics:
ANTIHYPOGLYCEMIC
ANTIDOTES
Diuretic
Antidiuretic
Vasodilator
Antihistamine

Source: http://www.myfirecompanies.com/filelock/12738164730.pdf

Report aleve positioning study

Highlights from 2008 Prime Access/PlanetOut Gay and Lesbian Consumer Study Prepared By: Overview • Conducted by Clark, Martire & Bartolomeo on behalf of Prime Access and PlanetOut, Inc., the 2008 Prime Access/PlanetOut Gay and Lesbian Consumer Report is one of the largest and most comprehensive studies of gay and lesbian consumer habits and brand perceptions. • 2,2

Microsoft word - intake form.doc

IDENTIFYING DATA: Last name: ___________________________ First name: __________________________ MI: _____________Birth date: ____________________________ Age: _________SS#: ____________ - __________ - ___________ and/orDriver’s License #: __________________________Address: _______________________________________ City: ______________ State: _____ Zip: ________Home phone: ___________________

Copyright © 2010-2018 Pharmacy Drugs Pdf